Addressing vulvovaginal atrophy (VVA)/genitourinary syndrome of menopause (GSM) for healthy aging in women

RE Nappi, E Martini, L Cucinella, S Martella… - Frontiers in …, 2019 - frontiersin.org
Vaginal health is an essential component of active and healthy aging in women at midlife
and beyond. As a consequence of hormonal deprivation and senescence, the anatomy and …

Genitourinary syndrome of menopause: a systematic review on prevalence and treatment

N Mili, SA Paschou, A Armeni, N Georgopoulos… - Menopause, 2021 - journals.lww.com
Objective: This article aimed to systematically review the literature to investigate the
prevalence of GSM and its treatment. Evidence Review: The search was conducted in the …

Effect of fractional carbon dioxide laser vs sham treatment on symptom severity in women with postmenopausal vaginal symptoms: a randomized clinical trial

FG Li, S Maheux-Lacroix, R Deans, E Nesbitt-Hawes… - Jama, 2021 - jamanetwork.com
Importance Postmenopausal vaginal symptoms are common and frequently detrimental to a
woman's quality of life. Fractional carbon dioxide vaginal laser is increasingly offered as a …

New innovations for the treatment of vulvovaginal atrophy: an up-to-date review

V Benini, AF Ruffolo, A Casiraghi, RS Degliuomini… - Medicina, 2022 - mdpi.com
Vulvovaginal atrophy (VVA) is a chronic progressive disease involving the female genital
apparatus and lower urinary tract. This condition is related to hypoestrogenism consequent …

Local oestrogen for pelvic floor disorders: a systematic review

MA Weber, MH Kleijn, M Langendam, J Limpens… - PLoS …, 2015 - journals.plos.org
Objective The decline in available oestrogen after menopause is a possible etiological factor
in pelvic floor disorders like vaginal atrophy (VA), urinary incontinence (UI), overactive …

The genitourinary syndrome of menopause

NA Phillips, GA Bachmann - Menopause, 2021 - journals.lww.com
Genitourinary syndrome of menopause (GSM) refers to a collection of symptoms resulting
from diminished hormonal, primarily estrogenic stimulation to the vulvovaginal or lower …

Microablative fractional CO2-laser therapy and the genitourinary syndrome of menopause: an observational study

E Pitsouni, T Grigoriadis, A Tsiveleka, D Zacharakis… - Maturitas, 2016 - Elsevier
Objectives This study aimed to assess the effect of the Microablative Fractional CO 2 Laser
(CO 2-laser) therapy on vaginal pathophysiology and the symptoms of the Genitourinary …

Vaginal laser therapy for GSM/VVA: where we stand now–a review by the EUGA Working Group on Laser

S Salvatore, AF Ruffolo, C Phillips, S Athanasiou… - …, 2023 - Taylor & Francis
Vulvovaginal atrophy (VVA) is a chronic progressive condition that involves the genital and
lower urinary tracts, related to the decrease of serum estrogenic levels when menopause …

The use of pulsed CO2 lasers for the treatment of vulvovaginal atrophy

S Stefano, A Stavros, C Massimo - Current Opinion in Obstetrics …, 2015 - journals.lww.com
The use of pulsed CO2 lasers for the treatment of vulvovagin... : Current Opinion in Obstetrics
and Gynecology The use of pulsed CO2 lasers for the treatment of vulvovaginal atrophy …

Pharmacotherapy for the treatment of vaginal atrophy

GGG Donders, K Ruban, G Bellen… - Expert opinion on …, 2019 - Taylor & Francis
Introduction: Despite its frequency, recognition and therapy of vulvovaginal atrophy (VVA)
remain suboptimal. Wet mount microscopy, or vaginal pH as a proxy, allows VVA diagnosis …